The stock is in a sustained long-term uptrend, evidenced by a 1-year price change of +33.28%, but is currently experiencing a significant correction from its recent highs. As of the latest close at $179.66, the price is positioned at approximately 59% of its 52-week range ($134.37 to $214.5), indicating a retreat from peak levels and suggesting a potential consolidation or value zone after a strong run. Recent momentum has turned sharply negative, with the stock down -11.33% over the past 3 months and underperforming the SPY by -21.61% on a relative basis, signaling a clear deceleration and loss of leadership. The 1-month performance of +3.98% offers a slight reprieve but remains weak relative to the market's +6.31% gain, indicating the stock is struggling to regain its footing amidst broader sector rotation or company-specific concerns. Key technical support is anchored at the 52-week low of $134.37, while immediate overhead resistance resides near the 52-week high of $214.5. A decisive break below the recent April lows around $172 could signal a deeper correction toward the $134 support, whereas a recovery above $200 would be needed to re-establish bullish momentum. The stock's beta of 0.30 indicates it is significantly less volatile than the broader market, which historically provided downside protection but has not prevented the recent sharp underperformance.

Revenue growth remains robust, with Q4 2025 revenue of $24.24 billion representing a 12.1% year-over-year increase, continuing a multi-quarter acceleration from the 8.5% YoY growth in Q3. The growth is broadly based across segments, with Pratt & Whitney ($17.13B), Collins Aerospace ($15.36B), and Raytheon Intelligence & Space ($14.66B) all contributing significant revenue. This trajectory underscores strong end-market demand in both commercial aerospace recovery and defense spending. Profitability is solid but showed some pressure in the latest quarter; Q4 2025 net income was $1.62 billion with a net margin of 6.7%, compared to a higher net margin of 8.5% in Q3. The gross margin for Q4 was 19.5%, slightly down from 20.4% in Q3, indicating potential cost inflation or mix shifts, while the operating margin held steady at 9.4%. The company is firmly profitable, with trailing twelve-month free cash flow of $7.94 billion supporting shareholder returns. The balance sheet is manageable with a debt-to-equity ratio of 0.61, indicating moderate leverage. Financial health is further supported by a current ratio of 1.03 and a return on equity of 10.3%. The substantial free cash flow generation, yielding a FCF/Share of approximately $5.91 based on the TTM figure, provides ample internal funding for growth, dividends (payout ratio of 53%), and debt reduction.